Knowledge, attitude, and practice of pharmacists regarding asthma management: a cross-sectional study in Egypt.

Asthma Attitude Knowledge Pharmacists Practice

Journal

Journal of pharmaceutical policy and practice
ISSN: 2052-3211
Titre abrégé: J Pharm Policy Pract
Pays: England
ID NLM: 101627192

Informations de publication

Date de publication:
03 May 2022
Historique:
received: 28 02 2022
accepted: 18 04 2022
entrez: 3 5 2022
pubmed: 4 5 2022
medline: 4 5 2022
Statut: epublish

Résumé

Asthma is a significant public health issue that poses a substantial health and economic burden. Despite the availability of effective asthma medications, its management remain suboptimal. Recent asthma guidelines have highlighted the importance of pharmacist unique position and its interventional strategies in positively impacting asthma treatment outcomes. Therefore, this study aimed to assess the degree of Egyptian pharmacists' knowledge, attitudes, as well as their practices towards asthma management in line with the recent asthma guidelines. This cross-sectional study was conducted among 800 pharmacists working in different private and governmental sectors. The data were collected using a 37-item pre-validated self-administered KAP questionnaire. The data were analyzed using Student's t-test and analysis of variance to assess the association between each KAP level and the sociodemographic variables at the significance level of 0.05. Of the 800 distributed questionnaire, a total of 550 participants (316 Male, and 234 Female) responded, representing a 68.7% response rate. The mean ± SD score of knowledge, attitude, practice, and barrier was 5.49 ± 1.65 (min = 0; max = 8), 23.5 ± 2.84 (min = 15, max = 30), 43.12 ± 8.61 (min = 28, max = 62), and 27.76 ± 3.72 (min = 17, max = 39), respectively. The results showed that poor knowledge, attitude, and practice scores were achieved by 30.54, 0, and 38.72% of participants, respectively. Our findings revealed the inconsistencies between poor pharmacists' knowledge and practices with respect to their positive attitudes. The lack of pharmacists' knowledge and compliance to recent GINA guidelines in this study highlight the crucial need for effective Educational strategies that should better equip pharmacists for their potential role in asthma care.

Sections du résumé

BACKGROUND BACKGROUND
Asthma is a significant public health issue that poses a substantial health and economic burden. Despite the availability of effective asthma medications, its management remain suboptimal. Recent asthma guidelines have highlighted the importance of pharmacist unique position and its interventional strategies in positively impacting asthma treatment outcomes. Therefore, this study aimed to assess the degree of Egyptian pharmacists' knowledge, attitudes, as well as their practices towards asthma management in line with the recent asthma guidelines.
METHODS METHODS
This cross-sectional study was conducted among 800 pharmacists working in different private and governmental sectors. The data were collected using a 37-item pre-validated self-administered KAP questionnaire. The data were analyzed using Student's t-test and analysis of variance to assess the association between each KAP level and the sociodemographic variables at the significance level of 0.05.
RESULTS RESULTS
Of the 800 distributed questionnaire, a total of 550 participants (316 Male, and 234 Female) responded, representing a 68.7% response rate. The mean ± SD score of knowledge, attitude, practice, and barrier was 5.49 ± 1.65 (min = 0; max = 8), 23.5 ± 2.84 (min = 15, max = 30), 43.12 ± 8.61 (min = 28, max = 62), and 27.76 ± 3.72 (min = 17, max = 39), respectively. The results showed that poor knowledge, attitude, and practice scores were achieved by 30.54, 0, and 38.72% of participants, respectively.
CONCLUSION CONCLUSIONS
Our findings revealed the inconsistencies between poor pharmacists' knowledge and practices with respect to their positive attitudes. The lack of pharmacists' knowledge and compliance to recent GINA guidelines in this study highlight the crucial need for effective Educational strategies that should better equip pharmacists for their potential role in asthma care.

Identifiants

pubmed: 35505447
doi: 10.1186/s40545-022-00432-0
pii: 10.1186/s40545-022-00432-0
pmc: PMC9062855
doi:

Types de publication

Journal Article

Langues

eng

Pagination

35

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

J Asthma Allergy. 2019 Aug 23;12:235-251
pubmed: 31692528
Curr Opin Pediatr. 2008 Dec;20(6):705-10
pubmed: 19005340
Explor Res Clin Soc Pharm. 2021 Jul 27;3:100051
pubmed: 35480619
Int J Clin Pharm. 2017 Aug;39(4):759-768
pubmed: 28466396
J Asthma. 2014 Nov;51(9):982-8
pubmed: 24856971
J Asthma. 2014 Nov;51(9):964-73
pubmed: 24986249
Respir Med. 2018 Nov;144:50-60
pubmed: 30366584
Pharm Pract (Granada). 2014 Jan;12(1):390
pubmed: 24644524
PLoS One. 2020 Jul 20;15(7):e0236114
pubmed: 32687539
Eur Respir J. 2008 Apr;31(4):790-9
pubmed: 18094011
Pharm Pract (Granada). 2012 Apr;10(2):110-5
pubmed: 24155826
Int J Tuberc Lung Dis. 2011 Dec;15(12):1574-87
pubmed: 21888756
Iran J Allergy Asthma Immunol. 2008 Jun;7(2):85-90
pubmed: 18552410
Ital J Pediatr. 2010 Apr 21;36:33
pubmed: 20406498
Pan Afr Med J. 2020 Sep 23;37:83
pubmed: 33244346
Ann Med Health Sci Res. 2014 Sep;4(Suppl 3):S253-8
pubmed: 25364598
J Asthma Allergy. 2019 May 24;12:109-153
pubmed: 31213852
J Grad Med Educ. 2013 Dec;5(4):541-2
pubmed: 24454995
Can Pharm J (Ott). 2016 Jul;149(4):216-8
pubmed: 27540403
Med Princ Pract. 2010;19(4):305-11
pubmed: 20516708
Women Birth. 2020 Mar;33(2):e166-e175
pubmed: 31208866
Saudi Pharm J. 2015 Oct;23(5):499-503
pubmed: 26594115
Respir Med. 2020 Nov - Dec;174:106199
pubmed: 33120195
Res Social Adm Pharm. 2018 Jun;14(6):603-611
pubmed: 28778676
J Asthma. 2021 Oct;58(10):1273-1277
pubmed: 32586146
J Pharm Pract. 2021 Feb;34(1):149-162
pubmed: 32495701
J Asthma. 2009 Apr;46(3):270-5
pubmed: 19373635
J Asthma. 2021 May;58(5):586-595
pubmed: 31910044
Int J Pharm Pract. 2010 Aug;18(4):209-16
pubmed: 20636672
BMJ. 2020 Aug 18;370:m2521
pubmed: 32816816
Saudi Pharm J. 2013 Apr;21(2):153-7
pubmed: 23960829

Auteurs

Amira S A Said (ASA)

Department of Clinical Pharmacy, College of Pharmacy, Al Ain University, Al Ain, Abu Dhabi, UAE. amira.ahmed@aau.ac.ae.
AAU Health and Biomedical Research Center (HBRC), Al Ain University, Abu Dhabi, UAE. amira.ahmed@aau.ac.ae.
Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni Suef, Egypt. amira.ahmed@aau.ac.ae.

Nadia Hussain (N)

AAU Health and Biomedical Research Center (HBRC), Al Ain University, Abu Dhabi, UAE.
Department of Pharmaceutical Sciences, College of Pharmacy, Al Ain University, Al Ain, Abu Dhabi, UAE.

Zelal Kharaba (Z)

Department of Clinical Pharmacy, College of Pharmacy, Al Ain University, Al Ain, Abu Dhabi, UAE.
AAU Health and Biomedical Research Center (HBRC), Al Ain University, Abu Dhabi, UAE.

Amal H I Al Haddad (AHI)

Chief Operations Office, Sheikh Shakbout Medical City (SSMC), Abu Dhabi, UAE.

Lamiaa N Abdelaty (LN)

Department of Clinical Pharmacy, Faculty of Pharmacy, October 6 University, Cairo, Egypt.

Raghda R S Hussein (RRS)

Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni Suef, Egypt.
Department of Clinical Pharmacy, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt.

Classifications MeSH